Director/PDMR Shareholding

RNS Number : 9639W
Dr. Martens PLC
23 August 2022
 

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the "Company") announces that it has been notified of the following transactions in the Company's Ordinary shares undertaken on behalf of directors / persons discharging managerial responsibility ('PDMRs') under the Company's Global Bonus Scheme.

Under the terms of the Company's Remuneration Policy, one third of any annual bonus payable to the Executive Directors each year, net of tax and national insurance, will be used to purchase shares which the Executive Directors are required to hold for two years.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kenny Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary shares under the Global Bonus Scheme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.75115

55,867 shares

d)

Aggregated information

-

Aggregated volume

-

Price

 

55,867 shares

£2.75115

e)

Date of the transaction

2022-07-25

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jon Mortimore

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary shares under the Global Bonus Scheme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.75115

26,936 shares

d)

Aggregated information

-

Aggregated volume

-

Price

 

26,936 shares

£2.75115

e)

Date of the transaction

2022-07-25

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOOORUWUWUAR

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings